PK Study of YH22189 FDC Compared to Combination of Telmisartan/Amlodipine and Rosuvastatin

NCT02608242 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

123

Enrollment

INDUSTRY

Sponsor class

Stopped sponsor decision

Conditions

Hypertension
Hyperlipidemia

Interventions

DRUG: YH22189
DRUG: Twynsta 80/10mg
DRUG: Crestor 20mg

Sponsor

Yuhan Corporation